NovaBay Pharmaceuticals, Inc. (NBY) — 分析师展望 / 分析师共识目标价为. 基于 5 位分析师评级, 共识为 看涨 — 2 买入, 3 持有.
分析师预估 每股收益(EPS)为 $-16.30 和 营收为 $0.01B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-2.53 vs 预期 $-16.30 (超预期 +84.5%). 2025: 实际 $-3.80 vs 预期 $-4.30 (超预期 +11.6%). 分析师准确度: 0%.
NBY 分析师评级
Hold
基于过去3个月内 5 位分析师对 NovaBay Pharmaceuticals, Inc. 的评级
EPS 预测 — NBY
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.53
vs Est –$16.30
▲ 544.3% off
2025
Actual –$3.80
vs Est –$4.30
▲ 13.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — NBY
98%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024
Actual $0.010B
vs Est $0.010B
▼ 2.2% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
